Auxilium Pharmaceuticals (AUXL) Posts Q3 Loss of 21c/Share; Boosts FY12 Outlook
Tweet Send to a Friend
Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL) reported Q3 EPS of ($0.21), $0.17 worse than the analyst estimate of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
